Bath & Body Works Surpasses Expectations in Q2 2026, Exceeding Sales and Earnings Projections
The Bath & Body Works' second quarter 2026 earnings conference call provided a detailed look at the company's performance during this period. The company exceeded its expectations, with net sales declining by 2.3%, outperforming its guidance range of down 5% to down 3%. Adjusted earnings per diluted share came in at $0.62, higher than the forecasted $0.20 to $0.25.
One notable aspect of the company's performance was the success of its recent product launches. The Fruit Fusion body care franchise saw a strong launch, meeting or exceeding sales expectations and achieving a higher average unit retail (AUR) compared to its core fragrant body care assortment. This franchise was designed as a hydration routine with distinctive fragrances paired with dermatologist-approved formulas that provide layering hydration throughout the day.
The company's focus on product innovation is evident in these launches, which aim to deliver better functionality and greater value to consumers. The introduction of functional packaging, such as the moisturizing body wash with a pump and more product at the same price, also demonstrates this commitment. These efforts contributed significantly to customer engagement, with several products selling out during the quarter.
In addition to its product-focused initiatives, Bath & Body Works emphasized the progress it has made against its Consumer First Formula. The company's strategic priorities include creating disruptive and innovative products, as well as investing in demand creation and consistent execution. The second quarter performance showed evidence of these efforts beginning to pay off, with sequential improvement in body care sales and growth in digital and expanded distribution channels.
Based on the results of Q2 2026, Bath & Body Works has adjusted its full-year guidance. It now projects a narrowed net sales decline range of down 4% at the low end and down 2.5% at the high end. Adjusted earnings per diluted share are forecasted to be between $2.60-$2.80, up from previous guidance.
The company remains committed to its Consumer First Formula and believes that returning Bath & Body Works to sustainable growth will take a multi-year transformation. It has outlined plans for continued investment in product innovation and demand creation, as well as consistent execution, to drive revenue growth in 2027.
With this clear direction, the company's focus shifts towards strengthening its underlying drivers of sustainable growth while tracking key indicators that validate its strategies are working ahead of schedule. This approach aims to lay the groundwork for a stronger performance in 2027 and beyond.
